Title : Reversal of nicotine-induced alveolar lipofibroblast-to-myofibroblast transdifferentiation by stimulants of parathyroid hormone-related protein signaling.

Pub. Date : 2007 May-Jun

PMID : 17401602






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Modulation of PTHrP-driven signaling can almost completely prevent nicotine-induced LIF-to-MYF transdifferentiation. Nicotine LIF interleukin 6 family cytokine Homo sapiens
2 Our objective was to determine if nicotine-induced LIF-to-MYF transdifferentiation could be reversed by specifically targeting the PTHrP-mediated alveolar epithelial-mesenchymal paracrine signaling. Nicotine LIF interleukin 6 family cytokine Homo sapiens
3 Nicotine-induced LIF-to-MYF transdifferentiation was almost completely reversed by treatment with RGZ, PTHrP, or DBcAMP, as determined by protein and functional assays. Nicotine LIF interleukin 6 family cytokine Homo sapiens
4 Using a specific molecular approach and targeting specific molecular intermediates in the PTHrP signaling pathway, to our knowledge, this for the first time, demonstrates the reversibility of nicotine-induced LIF-to-MYF transdifferentiation, suggesting not only the possibility of prevention but also the potential for reversal of nicotine-induced lung injury. Nicotine LIF interleukin 6 family cytokine Homo sapiens
5 Using a specific molecular approach and targeting specific molecular intermediates in the PTHrP signaling pathway, to our knowledge, this for the first time, demonstrates the reversibility of nicotine-induced LIF-to-MYF transdifferentiation, suggesting not only the possibility of prevention but also the potential for reversal of nicotine-induced lung injury. Nicotine LIF interleukin 6 family cytokine Homo sapiens